New scan could spare thousands from unnecessary kidney surgery
NCT ID NCT06076538
First seen Jan 05, 2026 · Last updated Jun 22, 2026 · Updated 25 times
Summary
This study is testing whether a combined PET/MR scan can better tell aggressive kidney cancers from harmless or slow-growing tumors. About 20% of kidney masses found by chance are not cancer, yet many are still treated. Researchers will scan 97 adults with suspicious kidney masses and compare the results to tissue samples if surgery is done. The goal is to reduce unnecessary procedures by improving how doctors classify these tumors.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RENAL CELL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Texas Southwestern Medical Center
RECRUITINGDallas, Texas, 75390, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
FDG (a radioactive tracer used in PET scans)
What this could lead to
If successful, this could help doctors avoid unnecessary surgery for benign or slow-growing kidney tumors by improving how they tell them apart from aggressive cancers.
What could go wrong
This is an early observational study with only 97 participants, so results may not apply to everyone. The scan may not reliably distinguish tumor types in practice.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.